Image

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System

Recruiting
18-99 years
All
Phase N/A

Powered by AI

Overview

The investigators hypothesize that the use of a personal hand hygiene system (SafeHavenTM) by anesthesia providers in the adult operating room, combined with a novel infectious pathogen tracking system (OR PathTrac) will decrease participant exposure to pathologic bacteria in the adult operating room.

Description

This will be a prospective, single center, unmasked, controlled before and after study.

Intervention Arm: Use of SafeHaven hand hygiene system in the operating room

Control Arm: Standard of care hand hygiene

Operating Room Selection: Two patients (case-pair) having surgery in a serial manner in a randomly selected operating room will be evaluated for detection of pathogenic bacteria. The operating room for investigation will be randomly selected through the following process:

  1. All the operating rooms with scheduled surgeries in the South Operating Rooms on a particular day will be entered into a random number generator (example: operating rooms 2, 3, 5, 7).
  2. The random generator will sort these operating rooms into a rank list (example: operating rooms 5, 3, 2, 7).
  3. The investigators will start at the top of this list and work down until the first operating room meeting all inclusion criteria is found (example: operating room 5 only has one surgery, operating room 3 has pediatric surgery, operating room 2 meets inclusion criteria)
  4. This process will be duplicated for each case-pair

The goal of the study is to map transmission of bacteria through the operating room and compare mapping with the SafeHaven Hand Hygiene system to mapping without the SafeHaven Hand Hygiene system. Thus, case-pairs will be randomized to the same assignment. For example, subject 1 and 2 will have surgery in South Operating Room 8 and both will be randomized to the control group. The first 10 case-pairs will be assigned to the control arm and the second 10 case-pairs will be assigned to the intervention arm.

Eligibility

Patient Inclusion Criteria:

        Patients ≥ 18 years of age having surgery in an adult operating suite at the research
        center involving the following specialties: orthopedics/spine, orthopedics/total joint,
        gynecology/oncology, colorectal, open vascular, and open urological, general abdominal,
        acute care, cardiothoracic, and plastic/breast.
        Patient Exclusion Criteria:
          -  Patients with a known infection at the time of surgery.
          -  Prisoners
          -  Pregnant Women
          -  Patients lacking capacity to consent
          -  Patients with an allergy to a component of hand hygiene solution, such as ethyl
             alcohol
          -  Refusal of consent
        Anesthesia Provider Inclusion Criteria:
        • Faculty physicians, resident physicians, or certified registered nurse anesthetists that
        provide care for adults having surgery at the research center.
        Anesthesia Provider Exclusion Criteria:
          -  Refusal of consent
          -  Open sores of the hands
          -  Known skin infection

Study details
    Surgical Wound Infection
    Cross Infection

NCT04900298

Oregon Health and Science University

22 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.